Global Oligonucleotide Synthesis Market Size study, By Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotides, Reagents, Equipment), By Application (Research Applications {PCR, Sequencing, Other Research Applications}, Diagnostic Applications), By Type (Antisense Oligonucleotide-Based Therapies, Rnai Oligonucleotide-Based Therapies, Cpg Oligonucleotide-Based Therapies, By Disease Type:, Neurological Disorders, Infectious Diseases, Other Diseases), By End-Use (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Cros And Cmos, Academic Research Institutes), and Regional Forecasts 2022-2028
- BIZ4950952
- 200 Pages
- March 2022
- Diagnostic and Biotech
Oligonucleotide synthesis is the chemical fusion of comparatively short fragments of nucleic acids with a defined chemical structure or sequence. The technique is majorly used in laboratory practice as it offers a fast and cost-effective way to contact custom-made oligonucleotides of the anticipated sequence. Moreover, it is also beneficial for performing molecular diagnosis in various diseases, involves detection of infectious diseases like SARS-COV2, hepatitis, and cancer diagnosis. The growing adoption of synthesized oligos in therapeutic applications, the with the growing focus on personalized medicin, coupled with the increasing number of government investments for synthetic biology and genome projects, are the major factors that may augment the market growth around the world. For instance, in August 2019, the Li Ka Shing Foundation (Hongkong) contributed USD 63 million for the introduction of the main institute for synthetic biology research at the Hong Kong University of Science and Technology (HKUST). The aim of this investment is to establish a new institute that will conduct research in synthetic biology for merging the processes and materials of biological systems & engineering. Moreover, in January 2020, in India, the Department of Biotechnology (DBT) introduced the “Genome India Project” (GIP) with the objective of accumulating10,000 genetic samples from citizens in India to create a reference genome. The major targeted areas of this project are rare genetic disorders, precision health, mutation spectrum of genetic & complex diseases that occur in the Indian population, translational research, and genetic epidemiology of multifactorial lifestyle diseases. However, complexities associated with therapeutic oligos impede the growth of the market over the forecast period of 2022-2028. Also, the growing presence of the leading market players in emerging economies is anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Oligonucleotide Synthesis Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing demand for high-quality research tools for data reproducibility and the presence of leading market players in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as increasing focus on improving the safety & quality of healthcare and developing personalized therapeutics, as well as increasing number of R&D activities in life sciences, would create lucrative growth prospects for the Oligonucleotide Synthesis Market across the Asia-Pacific region.
Major market players included in this report are:
Danaher Corporation
Thermo Fisher Scientific, Inc.
Merck KGaA
Maravai Life Sciences
Agilent Technologies, Inc.
Biogen Inc.
Sarepta Therapeutics, Inc.
LGC Biosearch Technologies
Bio-synthesis Inc.
TriLink BioTechnologies, LLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Oligonucleotide-based Drugs
Synthesized Oligonucleotides
Reagents
Equipment
By Application:
Research Applications
PCR
Sequencing
Other Research Applications
Diagnostic Applications
By Type:
Antisense Oligonucleotide-based Therapies
RNAi Oligonucleotide-based Therapies
CpG Oligonucleotide-based Therapies
By Disease Type:
Neurological Disorders
Infectious Diseases
Other Diseases
By End-Use:
Hospitals
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
CROs and CMOs
Academic Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Oligonucleotide Synthesis Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Oligonucleotide Synthesis Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Oligonucleotide Synthesis Market, by Product, 2020-2028 (USD Billion)
1.2.3. Global Oligonucleotide Synthesis Market, by Application, 2020-2028 (USD Billion)
1.2.4. Global Oligonucleotide Synthesis Market, by Type, 2020-2028 (USD Billion)
1.2.5. Global Oligonucleotide Synthesis Market, by Disease Type, 2020-2028 (USD Billion)
1.2.6. Global Oligonucleotide Synthesis Market, by End-Use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Oligonucleotide Synthesis Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Oligonucleotide Synthesis Market Dynamics
3.1. Oligonucleotide Synthesis Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing use of synthesized oligos in therapeutic applications
3.1.1.2. Increasing government investments for synthetic biology and genome projects
3.1.2. Market Challenges
3.1.2.1. Complexities associated with therapeutic oligos
3.1.3. Market Opportunities
3.1.3.1. Growing presence of the leading market players in emerging economies
Chapter 4. Global Oligonucleotide Synthesis Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Oligonucleotide Synthesis Market, by Product
6.1. Market Snapshot
6.2. Global Oligonucleotide Synthesis Market by Product, Performance - Potential Analysis
6.3. Global Oligonucleotide Synthesis Market Estimates & Forecasts by Product 2019-2028 (USD Billion)
6.4. Oligonucleotide Synthesis Market, Sub Segment Analysis
6.4.1. Oligonucleotide-based Drugs
6.4.2. Synthesized Oligonucleotides
6.4.3. Reagents
6.4.4. Equipment
Chapter 7. Global Oligonucleotide Synthesis Market, by Application
7.1. Market Snapshot
7.2. Global Oligonucleotide Synthesis Market by Application, Performance - Potential Analysis
7.3. Global Oligonucleotide Synthesis Market Estimates & Forecasts by Application 2019-2028 (USD Billion)
7.4. Oligonucleotide Synthesis Market, Sub Segment Analysis
7.4.1. Research Applications
7.4.1.1. PCR
7.4.1.2. Sequencing
7.4.1.3. Other Research Applications
7.4.2. Diagnostic Applications
Chapter 8. Global Oligonucleotide Synthesis Market, by Type
8.1. Market Snapshot
8.2. Global Oligonucleotide Synthesis Market by Type, Performance - Potential Analysis
8.3. Global Oligonucleotide Synthesis Market Estimates & Forecasts by Type 2019-2028 (USD Billion)
8.4. Oligonucleotide Synthesis Market, Sub Segment Analysis
8.4.1. Antisense Oligonucleotide-based Therapies
8.4.2. RNAi Oligonucleotide-based Therapies
8.4.3. CpG Oligonucleotide-based Therapies
Chapter 9. Global Oligonucleotide Synthesis Market, by Disease Type
9.1. Market Snapshot
9.2. Global Oligonucleotide Synthesis Market by Disease Type, Performance - Potential Analysis
9.3. Global Oligonucleotide Synthesis Market Estimates & Forecasts by Disease Type 2019-2028 (USD Billion)
9.4. Oligonucleotide Synthesis Market, Sub Segment Analysis
9.4.1. Neurological Disorders
9.4.2. Infectious Diseases
9.4.3. Other Diseases
Chapter 10. Global Oligonucleotide Synthesis Market, by End-Use
10.1. Market Snapshot
10.2. Global Oligonucleotide Synthesis Market by End-Use, Performance - Potential Analysis
10.3. Global Oligonucleotide Synthesis Market Estimates & Forecasts by End-Use 2019-2028 (USD Billion)
10.4. Oligonucleotide Synthesis Market, Sub Segment Analysis
10.4.1. Hospitals
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Diagnostic Laboratories
10.4.4. CROs and CMOs
10.4.5. Academic Research Institutes
Chapter 11. Global Oligonucleotide Synthesis Market, Regional Analysis
11.1. Oligonucleotide Synthesis Market, Regional Market Snapshot
11.2. North America Oligonucleotide Synthesis Market
11.2.1. U.S. Oligonucleotide Synthesis Market
11.2.1.1. Product estimates & forecasts, 2019-2028
11.2.1.2. Application estimates & forecasts, 2019-2028
11.2.1.3. Type estimates & forecasts, 2019-2028
11.2.1.4. Disease Type estimates & forecasts, 2019-2028
11.2.1.5. End-Use estimates & forecasts, 2019-2028
11.2.2. Canada Oligonucleotide Synthesis Market
11.3. Europe Oligonucleotide Synthesis Market Snapshot
11.3.1. U.K. Oligonucleotide Synthesis Market
11.3.2. Germany Oligonucleotide Synthesis Market
11.3.3. France Oligonucleotide Synthesis Market
11.3.4. Spain Oligonucleotide Synthesis Market
11.3.5. Italy Oligonucleotide Synthesis Market
11.3.6. Rest of Europe Oligonucleotide Synthesis Market
11.4. Asia-Pacific Oligonucleotide Synthesis Market Snapshot
11.4.1. China Oligonucleotide Synthesis Market
11.4.2. India Oligonucleotide Synthesis Market
11.4.3. Japan Oligonucleotide Synthesis Market
11.4.4. Australia Oligonucleotide Synthesis Market
11.4.5. South Korea Oligonucleotide Synthesis Market
11.4.6. Rest of Asia Pacific Oligonucleotide Synthesis Market
11.5. Latin America Oligonucleotide Synthesis Market Snapshot
11.5.1. Brazil Oligonucleotide Synthesis Market
11.5.2. Mexico Oligonucleotide Synthesis Market
11.6. Rest of The World Oligonucleotide Synthesis Market
Chapter 12. Competitive Intelligence
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. Danaher Corporation
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Product Summary
12.2.1.5. Recent Developments
12.2.2. Thermo Fisher Scientific, Inc.
12.2.3. Merck KGaA
12.2.4. Maravai Life Sciences
12.2.5. Agilent Technologies, Inc.
12.2.6. Biogen Inc.
12.2.7. Sarepta Therapeutics, Inc.
12.2.8. LGC Biosearch Technologies
12.2.9. Bio-synthesis Inc.
12.2.10. TriLink BioTechnologies, LLC
Chapter 13. Research Process
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption
TABLE 1. Global Oligonucleotide Synthesis Market, report scope
TABLE 2. Global Oligonucleotide Synthesis Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Oligonucleotide Synthesis Market estimates & forecasts by Product 2019-2028 (USD Billion)
TABLE 4. Global Oligonucleotide Synthesis Market estimates & forecasts by Application 2019-2028 (USD Billion)
TABLE 5. Global Oligonucleotide Synthesis Market estimates & forecasts by Type 2019-2028 (USD Billion)
TABLE 6. Global Oligonucleotide Synthesis Market estimates & forecasts by Disease Type 2019-2028 (USD Billion)
TABLE 7. Global Oligonucleotide Synthesis Market estimates & forecasts by End-Use 2019-2028 (USD Billion)
TABLE 8. Global Oligonucleotide Synthesis Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Oligonucleotide Synthesis Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Oligonucleotide Synthesis Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Oligonucleotide Synthesis Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Oligonucleotide Synthesis Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Oligonucleotide Synthesis Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Oligonucleotide Synthesis Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Oligonucleotide Synthesis Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. Global Oligonucleotide Synthesis Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. Global Oligonucleotide Synthesis Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 18. U.S. Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 19. U.S. Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. U.S. Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. Canada Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 22. Canada Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. Canada Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. UK Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 25. UK Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. UK Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. Germany Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 28. Germany Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. Germany Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. RoE Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 31. RoE Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. RoE Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. China Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 34. China Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. China Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. India Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 37. India Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. India Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. Japan Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 40. Japan Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. Japan Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. RoAPAC Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 43. RoAPAC Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. RoAPAC Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Brazil Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 46. Brazil Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Brazil Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. Mexico Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 49. Mexico Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. Mexico Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. RoLA Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 52. RoLA Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. RoLA Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. Row Oligonucleotide Synthesis Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 55. Row Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 56. Row Oligonucleotide Synthesis Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 57. List of secondary sources, used in the study of global Oligonucleotide Synthesis Market
TABLE 58. List of primary sources, used in the study of global Oligonucleotide Synthesis Market
TABLE 59. Years considered for the study
TABLE 60. Exchange rates considered
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
